{"meta":{"query_hash":"f99a8f61fe61","filters":{"venue":"Video Journal of Biomedicine"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f99a8f61fe61","api":"https://metacan.xera.ac/api/v1/cohort?venue=Video+Journal+of+Biomedicine"},"results":[{"id":"W4243114708","doi":"10.2217/vjbm-2020-0011","title":"Designing and developing therapeutic proteins with Jumi Shin ","year":2020,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Engineering ethics; Perspective (graphical); Work (physics); Management science; Data science; Sociology; Engineering; Computer science; Artificial intelligence; Mechanical engineering","score_opus":0.05569858185442358,"score_gpt":0.31054079875229623,"score_spread":0.2548422168978727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243114708","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066922136,0.22579236,0.33944842,0.12156746,0.041312538,0.00055548165,0.00053483684,0.0051519955,0.19871472],"genre_scores_gemma":[0.22723255,0.15633751,0.2737054,0.034234077,0.007611849,0.0006316132,0.0007971976,0.001374792,0.29807502],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944574,0.00013264667,0.000017977061,0.00010991144,0.00022663442,0.00006710945],"domain_scores_gemma":[0.9996325,0.000091796,0.000028650269,0.000016231752,0.00007888075,0.00015200344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015903845,0.0008306345,0.00036851395,0.00040172852,0.0010269661,0.0015733091,0.0006220817,0.0012565253,0.006074464],"category_scores_gemma":[0.0011067527,0.00046917773,0.0005070722,0.0003437613,0.0012164615,0.0019233017,0.0013403025,0.0035257281,0.0027117273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008910586,0.0002793983,0.0008406861,0.0017266779,0.00008460322,0.0014359715,0.0031618364,0.002231028,0.38703206,0.08780229,0.25377595,0.26073837],"study_design_scores_gemma":[0.00005827177,0.00030356625,0.00025526644,0.00016375298,0.000033330038,0.0007582154,0.00044814238,0.0012063321,0.07018684,0.006161068,0.9203757,0.00004943678],"about_ca_topic_score_codex":0.0011635498,"about_ca_topic_score_gemma":0.002296891,"teacher_disagreement_score":0.006074464,"about_ca_system_score_codex":0.0009980449,"about_ca_system_score_gemma":0.000864607,"threshold_uncertainty_score":0.020321071},"labels":[],"label_agreement":null},{"id":"W4313639990","doi":"10.2217/vjbm-2023-0001","title":"A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets","year":2023,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"Deutsche Forschungsgemeinschaft; EMD Serono; GW Pharmaceuticals; CSL Behring; Teva Pharmaceutical Industries; Bundesministerium für Bildung und Forschung; Biogen; Fresenius Medical Care North America; Celgene; Merck KGaA; Sanofi","keywords":"Cladribine; Multiple sclerosis; Medicine; Chickenpox; Immunology; Intensive care medicine; Virus; Internal medicine","score_opus":0.025097063949904977,"score_gpt":0.2882615105151259,"score_spread":0.2631644465652209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313639990","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01629095,0.034229018,0.003011302,0.14180364,0.08705026,0.0033206572,0.24837959,0.00268697,0.46322754],"genre_scores_gemma":[0.09271156,0.07556431,0.011780521,0.09611373,0.072183065,0.004836581,0.10619888,0.0017589781,0.5388524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997645,0.00007142309,0.00002050584,0.000016336493,0.000081658865,0.0000456208],"domain_scores_gemma":[0.9974038,0.0013066685,0.0002180781,0.000032487173,0.0006985064,0.00034045972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051373045,0.00057951227,0.0005440782,0.0009790885,0.0004520135,0.0008331585,0.00040532218,0.0010905644,0.2606423],"category_scores_gemma":[0.0054725073,0.0001266776,0.00067297625,0.00078476506,0.00014998621,0.00066387636,0.000388564,0.0013086954,0.026542258],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024924925,0.000027574084,0.0002170647,0.0005398048,0.000009700557,0.00015032722,0.000040825296,0.00003147951,0.0001173673,0.00015496206,0.9808904,0.017571364],"study_design_scores_gemma":[0.0003911499,0.00043716564,0.0067332806,0.0023575875,0.000047774898,0.00068789127,0.00027644387,0.00018527306,0.00027297757,0.000479862,0.9880959,0.000034680426],"about_ca_topic_score_codex":0.00914361,"about_ca_topic_score_gemma":0.01198554,"teacher_disagreement_score":0.2606423,"about_ca_system_score_codex":0.00078368705,"about_ca_system_score_gemma":0.00091691676,"threshold_uncertainty_score":0.8719353},"labels":[],"label_agreement":null},{"id":"W4387459404","doi":"10.2217/vjbm-2023-0008","title":"Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease","year":2023,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Empagliflozin; Type 2 diabetes; Medicine; Kidney disease; Diabetes mellitus; Intensive care medicine; Disease; Internal medicine; Endocrinology","score_opus":0.015706956849606834,"score_gpt":0.28423237653799477,"score_spread":0.26852541968838795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387459404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6847085,0.14183676,0.01850695,0.06717322,0.005460158,0.0025483745,0.009330167,0.0008244153,0.06961154],"genre_scores_gemma":[0.9193003,0.02735254,0.011585356,0.021328604,0.0058021024,0.00091187947,0.004188174,0.000089253,0.009441923],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980775,0.0008310401,0.00012883381,0.00013170374,0.00074786873,0.000083027284],"domain_scores_gemma":[0.9941057,0.0025253221,0.0009900235,0.00016884907,0.0017403082,0.00046988257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039531556,0.0002667771,0.0005633584,0.00044178325,0.000275692,0.0006739705,0.00028509495,0.00088288647,0.003508955],"category_scores_gemma":[0.01153341,0.00009846191,0.0010832864,0.00029304353,0.00021977519,0.00046235582,0.00026021272,0.0012752212,0.00042910496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054598738,0.0017344046,0.03428921,0.0020311654,0.001231849,0.0007108044,0.00018843048,0.0008888624,0.015027445,0.0010356691,0.053801697,0.83446175],"study_design_scores_gemma":[0.046416722,0.21754986,0.25159645,0.0047746236,0.00762273,0.0101004755,0.0005596372,0.015269575,0.078968994,0.0049249604,0.36187267,0.000343217],"about_ca_topic_score_codex":0.0007029116,"about_ca_topic_score_gemma":0.0009971102,"teacher_disagreement_score":0.0039531556,"about_ca_system_score_codex":0.00072631653,"about_ca_system_score_gemma":0.00075473316,"threshold_uncertainty_score":0.020906568},"labels":[],"label_agreement":null},{"id":"W4407771126","doi":"10.1080/vjbm-2024-0012","title":"Spesolimab Treatment for the Prevention of Flares in People with Generalized Pustular Psoriasis (GPP): A Video Summary of the EFFISAYIL® 2 Study","year":2025,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Generalized pustular psoriasis; Psoriasis; Medicine; Dermatology; Pustular psoriasis","score_opus":0.015312262566978192,"score_gpt":0.2747713921648219,"score_spread":0.2594591295978437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407771126","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030459587,0.5208644,0.0045257146,0.1271016,0.03324246,0.0053982227,0.062888674,0.0010299241,0.2144895],"genre_scores_gemma":[0.15069544,0.5025995,0.016643725,0.08032927,0.07098819,0.0033280784,0.04689623,0.00047654138,0.12804313],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999705,0.00009808241,0.000020700827,0.00002132977,0.00010884082,0.000045993635],"domain_scores_gemma":[0.9992969,0.00030008578,0.00011544792,0.0000110372175,0.00012496153,0.00015158593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000752674,0.0005410732,0.00057384,0.0007043499,0.00024095464,0.00056715513,0.0003093849,0.0009938793,0.042390916],"category_scores_gemma":[0.0017044313,0.00015352081,0.00090767903,0.0005359363,0.00009728067,0.00034428603,0.00020391421,0.0010031846,0.004551551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005745467,0.00028754413,0.0007530726,0.0045339274,0.00024593662,0.00038983158,0.000053499807,0.00017390914,0.0018153159,0.00054633064,0.62725395,0.35820124],"study_design_scores_gemma":[0.011085214,0.006616406,0.020651499,0.0060271393,0.0008961722,0.0016250038,0.0001231071,0.00049065903,0.002086771,0.0014257723,0.9489024,0.000069850656],"about_ca_topic_score_codex":0.0037863061,"about_ca_topic_score_gemma":0.009442317,"teacher_disagreement_score":0.042390916,"about_ca_system_score_codex":0.0005765337,"about_ca_system_score_gemma":0.00048805992,"threshold_uncertainty_score":0.14181173},"labels":[],"label_agreement":null},{"id":"W4415877690","doi":"10.1080/vjbm-2025-0004","title":"Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study","year":2025,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Cladribine; Multiple sclerosis; Immune system; Biomarker; Immunotherapy","score_opus":0.027644601580808312,"score_gpt":0.27615287588419757,"score_spread":0.24850827430338926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415877690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99052036,0.0012110942,0.00025020054,0.0004141962,0.000045906945,0.0000861133,0.0054260786,0.000030912397,0.0020151504],"genre_scores_gemma":[0.9924964,0.0007861391,0.00048403305,0.0003363144,0.00010348001,0.00010925093,0.003919593,0.000007899098,0.0017568046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986696,0.000034647594,0.000010799487,0.000029242105,0.000036883892,0.000021499927],"domain_scores_gemma":[0.9994363,0.0001086441,0.00014629928,0.000028609074,0.00015671868,0.00012342542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005465533,0.00018142952,0.00042629766,0.0003503125,0.000300307,0.00037700735,0.0001278295,0.0005364597,0.0016225035],"category_scores_gemma":[0.0013363862,0.00011438256,0.0004197353,0.00039514343,0.000083424646,0.00033238684,0.00028464003,0.0006199013,0.00031803167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0113242045,0.0009797288,0.91742873,0.00028958792,0.00045499526,0.001052269,0.0012075556,0.00024162426,0.003565767,0.00010684765,0.009438048,0.05391071],"study_design_scores_gemma":[0.00015985328,0.0018535438,0.99465454,0.00003314631,0.00015424265,0.00029052695,0.00037802034,0.00016985941,0.00024914628,0.00004638728,0.0019912175,0.000019551586],"about_ca_topic_score_codex":0.0051119006,"about_ca_topic_score_gemma":0.0052712904,"teacher_disagreement_score":0.0051119006,"about_ca_system_score_codex":0.0002582848,"about_ca_system_score_gemma":0.00020512068,"threshold_uncertainty_score":0.0101643205},"labels":[],"label_agreement":null}]}